NCT00571025View on ClinicalTrials.gov

Risk Evaluation and Education for Alzheimer's Disease

NACompletedINTERVENTIONAL
Enrollment

301

Participants

Timeline

Start Date

August 31, 2000

Study Completion Date

April 30, 2004

Conditions
Alzheimer's Disease
Interventions
BEHAVIORAL

APOE Disclosure

Individuals are provided with a lifetime percentage risk of developing Alzheimer's disease and told their own APOE genotype.

Trial Locations (3)

10021

Weill Medical College of Cornell University, New York

44120

Case Western Reserve University, Cleveland

02118

Boston University School of Medicine, Boston

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

National Human Genome Research Institute (NHGRI)

NIH

NCT00571025 - Risk Evaluation and Education for Alzheimer's Disease | Biotech Hunter | Biotech Hunter